![](/img/cover-not-exists.png)
Guselkumab efficacy after withdrawal is associated with suppression of serum IL-23-regulated IL-17 and IL-22 in psoriasis: VOYAGE 2 study
Gordon, Kenneth B., Armstrong, April W., Foley, Peter, Song, Michael, Shen, Yaung-Kaung, Li, Shu, Muñoz-Elías, Ernesto J., Branigan, Patrick, Liu, Xuejun, Reich, KristianLanguage:
english
Journal:
Journal of Investigative Dermatology
DOI:
10.1016/j.jid.2019.05.016
Date:
June, 2019
File:
PDF, 563 KB
english, 2019